147 related articles for article (PubMed ID: 33817786)
1. Disease-modifying treatment with I
Vasilopoulou F; Rodríguez-Arévalo S; Bagán A; Escolano C; Griñán-Ferré C; Pallàs M
Br J Pharmacol; 2021 Aug; 178(15):3017-3033. PubMed ID: 33817786
[TBL] [Abstract][Full Text] [Related]
2. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease.
Mirzaei N; Mota BC; Birch AM; Davis N; Romero-Molina C; Katsouri L; Palmer EOC; Golbano A; Riggall LJ; Nagy I; Tyacke R; Nutt DJ; Sastre M
Br J Pharmacol; 2021 Feb; 178(3):654-671. PubMed ID: 33140839
[TBL] [Abstract][Full Text] [Related]
3. Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model.
Vasilopoulou F; Escolano C; Pallàs M; Griñán-Ferré C
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573297
[TBL] [Abstract][Full Text] [Related]
4. I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice.
Mota BC; Ashburner N; Abelleira-Hervas L; Liu L; Aleksynas R; Rovati LC; Caselli G; Sastre M
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806327
[TBL] [Abstract][Full Text] [Related]
5. Benzofuranyl-2-imidazoles as imidazoline I
Rodriguez-Arévalo S; Bagán A; Griñán-Ferré C; Vasilopoulou F; Pallàs M; Brocos-Mosquera I; Callado LF; Loza MI; Martínez AL; Brea J; Pérez B; Molins E; De Jonghe S; Daelemans D; Radan M; Djikic T; Nikolic K; Hernández-Hernández E; García-Fuster MJ; García-Sevilla JA; Escolano C
Eur J Med Chem; 2021 Oct; 222():113540. PubMed ID: 34118720
[TBL] [Abstract][Full Text] [Related]
6. Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice.
Choi HJ; Park JH; Jeong YJ; Hwang JW; Lee S; Lee H; Seol E; Kim IW; Cha BY; Seo J; Moon M; Hoe HS
Mol Brain; 2022 Jul; 15(1):63. PubMed ID: 35850693
[TBL] [Abstract][Full Text] [Related]
7. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
Ju Y; Tam KY
Neuropharmacology; 2020 Dec; 181():108354. PubMed ID: 33035533
[TBL] [Abstract][Full Text] [Related]
8. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis.
Maiti P; Bowers Z; Bourcier-Schultz A; Morse J; Dunbar GL
Alzheimers Res Ther; 2021 Feb; 13(1):37. PubMed ID: 33557949
[TBL] [Abstract][Full Text] [Related]
9. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
10. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
Batarseh YS; Kaddoumi A
J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
[TBL] [Abstract][Full Text] [Related]
11. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
[TBL] [Abstract][Full Text] [Related]
12. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice.
Jiang Y; Li K; Li X; Xu L; Yang Z
Chem Biol Interact; 2021 May; 341():109452. PubMed ID: 33785315
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer's Disease.
Maiti P; Manna J; Burch ZN; Flaherty DB; Larkin JD; Dunbar GL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933008
[TBL] [Abstract][Full Text] [Related]
14. Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice.
Jiang LX; Huang GD; Su F; Wang H; Zhang C; Yu X
Psychopharmacology (Berl); 2020 Apr; 237(4):1233-1243. PubMed ID: 31953648
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I
Vasilopoulou F; Bagan A; Rodriguez-Arevalo S; Escolano C; Griñán-Ferré C; Pallàs M
Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32456135
[TBL] [Abstract][Full Text] [Related]
16. Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease mice.
Beitnere U; van Groen T; Kumar A; Jansone B; Klusa V; Kadish I
J Neurosci Res; 2014 Mar; 92(3):338-46. PubMed ID: 24273007
[TBL] [Abstract][Full Text] [Related]
17. Donecopride, a Swiss army knife with potential against Alzheimer's disease.
Rochais C; Lecoutey C; Hamidouche K; Giannoni P; Gaven F; Cem E; Mignani S; Baranger K; Freret T; Bockaert J; Rivera S; Boulouard M; Dallemagne P; Claeysen S
Br J Pharmacol; 2020 May; 177(9):1988-2005. PubMed ID: 31881553
[TBL] [Abstract][Full Text] [Related]
18. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
[TBL] [Abstract][Full Text] [Related]
19. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of combined therapy with memantine, donepezil, and vitamin D in ovariectomized female mice subjected to dementia model.
Vieira ADC; Medeiros EB; Zabot GC; Pereira NS; do Nascimento NB; Lidio AV; Scheffer ÂK; Rempel LCT; Macarini BMN; Costa MA; Gonçalves CL; Kucharska E; Rodrigues MS; Moreira JCF; de Oliveira J; Budni J
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 122():110653. PubMed ID: 36195205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
